Delivery Order SPE2DR25D1202-SPE2DR26F74LA
Award Date 2/3/26
Potential Completion Date 2/4/26
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,962.99 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $14,532.25. This firm fixed-price delivery order, which carries an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $21,526.80 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). This firm fixed-price delivery order, awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order valued at $36,633.12 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on January 29, 2026, with completion expected by January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,097.78 for Ondansetron ODT 4 mg tablets (30-count supply) on November 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance is scheduled for completion by December 1, 2025, and work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,259.48 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count package) on January 21, 2026, with ultimate completion by January 22, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,487.77 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) on January 22, 2026, with completion scheduled for January 23, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Ondansetron ODT 4 mg tablets (30-count packaging) with a ceiling value of $2,173.14 and a firm fixed-price structure. This delivery order was issued without a set-aside designation, indicating full and open competition. The contract is scheduled for ultimate completion on January 15, 2026, with performance occurring at the vendor's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $23,772.45 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on November 28, 2025, with an ultimate completion date of December 1, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 13, 2026, for the supply of Ondansetron ODT 4 mg tablets in a quantity of 30 units, with a ceiling value of $1,081.27. This is a firm fixed-price contract with an ultimate completion date of January 14, 2026, and represents a competitively awarded, non-set-aside procurement. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen maintains its...